Pensar Medical, a leading innovator in negative pressure wound therapy (NPWT), today announced a strategic partnership with Centurion Therapeutics for the distribution of its Microdoc® sNPWT (single-use negative pressure wound therapy) platform. This collaboration is poised to enhance patient care by expanding access to advanced wound management solutions across the United States.

The Microdoc® sNPWT system is designed to offer cost-effective and efficient treatment for both chronic and acute wounds. By combining Pensar Medical's cutting-edge technology with Centurion Therapeutics' extensive distribution network, this partnership aims to drive widespread adoption of the Microdoc® platform. With over 500 sales professionals operating in more than 600 sites of care, the alliance is well-positioned to deliver the proven benefits of sNPWT to a broader patient population.

The market for single-use negative pressure wound therapy (sNPWT) is valued at approximately $400 million annually, with a growth rate exceeding 20% per year. This expansion is driven by clinical evidence showing that sNPWT can reduce surgical site infections and accelerate healing. Surgical site infections currently cost the U.S. healthcare system over $3.3 billion annually, and devices like Microdoc® have the potential to reduce this risk by more than 50%.

"We are thrilled to partner with Centurion Therapeutics," said Jason Bandy, CEO of Pensar Medical. "Their strong presence and rapid growth in the inpatient market, combined with our novel NPWT technology, will enable us to reach more patients and improve outcomes."

Robert Goodwin, President and CEO of Centurion Therapeutics, echoed this enthusiasm: "Adding the Microdoc® sNPWT system to our product portfolio aligns perfectly with our commitment to providing comprehensive wound and surgical management solutions nationwide. We are excited about the opportunity to offer this innovative product to our distribution partners and their customers."

This partnership marks a significant step forward in the mission of both companies to advance wound care and improve patient outcomes through innovative medical technologies.